BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1686935)

  • 1. Growth hormone-releasing hormone and somatostatin in normal and tumoral human pituitaries.
    Benlot C; Pagesy P; Peillon F; Joubert-Bression D
    Peptides; 1991; 12(5):945-50. PubMed ID: 1686935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence and characterization of the somatostatin precursor in normal human pituitaries and in growth hormone secreting adenomas.
    Levy L; Bourdais J; Mouhieddine B; Benlot C; Villares S; Cohen P; Peillon F; Joubert D
    J Clin Endocrinol Metab; 1993 Jan; 76(1):85-90. PubMed ID: 8093621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
    Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
    J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M; Williams TC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
    Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
    J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro].
    Peillon F; Le Dafniet M; Garnier P; Feinstein MC; Donnadieu M; Barret A; Gautron JP; Brandi AM; Benlot C; Lagoguey A
    Pathol Biol (Paris); 1989 Sep; 37(7):840-5. PubMed ID: 2576565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T; Hotta M; Masuda A; Imaki T; Obara N; Hizuka N; Takano K; Wakabayashi I; Demura H; Ling N
    J Clin Endocrinol Metab; 1986 Jul; 63(1):167-73. PubMed ID: 2872226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly.
    Giustina A; Schettino M; Bodini C; Doga M; Licini M; Giustina G
    Metabolism; 1992 Dec; 41(12):1291-4. PubMed ID: 1281259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M; Frohman LA
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocrine and paracrine effects of peptides on human pituitary cells.
    Joubert D; Mouhieddine B; Benlot C; Levy L; Peillon F
    Horm Res; 1992; 38(1-2):100-4. PubMed ID: 1363983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
    Ikuyama S; Nawata H; Kato K; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
    Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
    Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone releasing hormone-sensitive adenylate cyclase activity in growth hormone-producing pituitary adenoma: correlation to the response of plasma growth hormone to growth hormone releasing hormone in patients with acromegaly.
    Natori S; Ikuyama S; Haji M; Ohashi M; Nawata H
    Endocrinol Jpn; 1989 Apr; 36(2):229-36. PubMed ID: 2550207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin cells in human somatotropic adenomas.
    Li JY; Pagesy P; Berthet M; Racadot O; Kujas M; Racadot J; Peillon F
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(1):95-101. PubMed ID: 1347188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.